Thrombotic thrombocytopenic purpura: Description and analysis of 23 cases treated in Chile between 2017 and 2022

Introduction Since the first description of Thrombotic Thrombocytopenic Purpura, caused by a severe deficiency of ADAMTS13, plasma exchange and immunosuppression have become standard treatments, allowing to decrease its high mortality rate. Prospective records of Thrombotic Thrombocytopenic Purpura...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Daniel Cathalifaud, Jean-Paul Manríquez, Benjamín Rodríguez, Gonzalo Eymin, Benjamín Sanfuentes, Joel Castellano, Andrés Valenzuela
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Medwave Estudios Limitada 2025-07-01
Ráidu:	Medwave
Fáttát:	thrombotic thrombocytopenic purpura thrombotic microangiopathies adamts13 protein plasma exchange case series
Liŋkkat:	https://www.medwave.cl/investigacion/estudios/3002.html
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!